Systematic review of data from randomized controlled trials on the efficacy, safety and tolerability of drugs used to treat painful diabetic neuropathy

Journal of Pain Management

Volumn 4, Issue 4, 2011, Pages 339-351

  Edelsberg, John ^a   Lord, Claudia ^a   Oster, Gerry ^a  

^a POLICY ANALYSIS INC PAI   (United States)

Author keywords

Diabetic peripheral neuropathy; Meta analysis; Neuropathic pain; Systematic review; Treatment

Indexed keywords

ANTIPAIN; CAPSAICIN; DULOXETINE; GABAPENTIN; GLYCERYL TRINITRATE; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; OXYCODONE; PLACEBO; PREGABALIN; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

ASTHENIA; CLINICAL ASSESSMENT TOOL; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; FATIGUE; HEADACHE; HUMAN; MEDLINE; META ANALYSIS; NAUSEA; NUMERIC RATING SCALE; PAIN; PAIN ASSESSMENT; PAINFUL DIABETIC NEUROPATHY; REVIEW; RISK FACTOR; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

EID: 84155187192     PISSN: 19395914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51.
2. Hansson PT, Dickenson AH. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 2005;113:215-54.
3. Gallagher RM. Management of neuropathic pain: Translating mechanistic advances and evidence-based research into clinical practice. Clin J Pain 2006;22(suppl 1):S2-8.
4. Edelsberg J, Oster G. Summary measures of number needed to treat: How much clinical guidance do they provide in neuropathic pain? Eur J Pain 2009;13:11-6.
5. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta- analysis of randomized controlled trials. JAMA 2005;293:3043-52.
6. Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: A systematic review of meta- analysis. Anesth Analg 2005; 101:1738-49.
7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials. Is blinding necessary? Control Clin Trials 1996;17:1-12.
8. Explanation of Columns in Natural Standard Evidence Table. Accessed 2010 Feb 8. URL: http://www.naturalstandard.com/explanation_columns.html
9. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy: Controlled study with long-term follow-up. Diabetes Care 1992;15:8-14.
10. Scheffler N, Sheitel P, Lipton M. Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Podiatr Med Assoc 1991; 81:288-93.
11. Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006;67:1411-20.
12. Raskin J, Pritchett Y, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346-56.
13. Goldstein D, Lu Y, Detke M, Lee T, Iyengar S. Duloxetine vs. Placebo in patients with painful diabetic neuropathy. Pain 2005; 116:109-118.
14. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.
15. Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Nueromuscular Dis 2001;3:53-62.
16. Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, White J, Silver M. Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double- blind, placebo-controlled studies. Pain 2007; 128:169-79.
17. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001;57:505-9.
18. Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: Results of a dose-ranging study. Acta Neurol Scand 2006;113:395-404.
19. Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: A randomized, placebo-controlled study. Eur J Pain 2005;9:543-54.
20. Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2006;114:177-80.
21. Arezzo JC, Rosenstock J, LaMoreaux L, Pauer L. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial. BMC Neurology 2008;8:33.
22. Freynhagen R, Strokek K, Griesing T, Whalen E, Balkenohl M. Efficacy pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005;115:254-63.
23. Lesser H, Sharma U, LaMoreaux L, Poole. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004;63:2104-10.
24. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005; 6:253-60.
25. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004;110:628-38.
26. Tölle T, Freynhagen R, Versavel M, Trostmann U, Young Jr. JP. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double-blind study. Eur J Pain 2008; 12:203-13.
27. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI. Topiramate vs. placebo in painful diabetic neuropathy: Analgesic and metabolic effects. Neurology 2004;63:865-73.
28. Gimbel J, Richards P, Portenoy K. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003;60:927-34.
29. Watson C, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105:71-8.
30. Atli A, Dogra S. Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study. Pain Med 2005;6:225-34.
31. Freeman R, Raskin P, Hewitt DJ, Vorsanger GJ, Jordan DM, Xiang J, Rosenthal NR. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 2007;23:147-61.
32. Agrawal RP, Goswami J, Jain S, Kochar DK. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo=controlled study. Diabetes Res Clin Practice 2009;83:371-378.
33. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, Garg P. Sodium valporate for painful diabetic neuropathy: A randomized double-blind placebo- controlled study. Q J Med 2004; 33-38.
34. Agrawal RP, Choudhary R, Sharma P, Sharma S, Beniwal R, Kaswan K, Kochar DK. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: A randomized double blind placebo controlled cross-over study. Diabetes Res Clin Practice 2007;77:161-7.
35. Kadiroglu AK, Sit D, Kayabasi H, Tuzcu AK, Tasdemir N, Yilmaz ME. The effect of velafaxine HCI on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabet Complications 2008;22:241-5.
36. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study. Pain 2004;110:697-706.
37. Wymer JP, Simpson J, Sen D, Bongardt S. Efficacy and safety of lacosamide in diabetic neuropathic pain. An 18 week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009; 25:376-85.
38. Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995; 12:111-120.
39. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: An open-label pilot study. J Pain Symptom Manage 2000;20:280-5.
40. Gómez-Pérez FJ, Choza R, Ríos JM, Reza A, Huerta E, Aguilar CA, Rull JA. Nortriptyline-fluphenazine vs. carbamazepine in symptomatic treatment of diabetic neuropathy. Arch Med Res 1996; 27:525-9.
41. Jose VM, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy. Diabet Med 2007; 24:377-83.
42. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-6.
43. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
44. American Diabetes Association. Standards of Medical Care in Diabetes - 2009. Diabetes Care 2009;32:S13-S61.
45. Quillici S, Chancellor J, Löthgren M, Simon D, Said G, Le TK, Garcia-Cebrian A, Monz B. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain. BMC Neurology 2009;9:1471-7.
46. Gutierrez-Alvarez AM, Beltran-Rodriguez J, Moreno CB. Antiepileptic drugs in treatment of pain caused by diabetic neuropathy. J Pain Symptom Manag 2007;34:201-8.
47. Chong SM, Hester J. Diabetic painful neuropathy. Current and future treatment options. Drugs 2007;67:569-85.
48. Adriaensen H, Plaghki L, Joffroy A, Vissers K. Critical review of oral drug treatments for diabetic neuropathic pain -Clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab Res Rev 2005;1:231-40.
49. Wilton TD. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;48:18.
50. National Institute for Health and Clinical Excellence (NICE). Neuropathic pain: The pharmacological management of neuropathic pain in adults in non- specialist settings. London: NICE 2010. Accessed 2010 May 20.URL: http://www.nice.org.uk/nicemedia/live/12948/47936/47936.pdf.
51. Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: A practical guide from the clinician. CMAJ 2006;175:265-75.
52. Mendell J, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-55.
53. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurology 2006;13:1153-69.